Shigeto Maeda

Clinical Implication of Hot Spot<i>BRAF</i>Mutation, V599E, in Papillary Thyroid Cancers

Hiroyuki Namba, Masahiro Nakashima, Tomayoshi Hayashi et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 534 citations

Braf Mutation, Clinical Implication, Braf Gene +12

<i>Ets</i>-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells

Shinji Naito, Shunichi Shimizu, Shigeto Maeda et al. · American Journal of Physiology-Cell Physiology · 1998 · 117 citations

Ets-1 Mrna, Cellular Physiology, Transcriptional Regulation +22

Analysis of Osteocalcin Expression in Transgenic Mice Reveals a Species Difference in Vitamin D Regulation of Mouse and Human Osteocalcin Genes

Thomas L. Clemens, Hui Tang, Shigeto Maeda et al. · Journal of Bone and Mineral Research · 1997 · 90 citations · Full text

Induction of Thyroid Cancer Cell Apoptosis by a Novel Nuclear Factor κB Inhibitor, Dehydroxymethylepoxyquinomicin

Dmitriy Starenki, Hiroyuki Namba, Vladimir Saenko et al. · Clinical Cancer Research · 2004 · 85 citations · Full text

Aberrant Localization of β-Catenin Correlates with Overexpression of Its Target Gene in Human Papillary Thyroid Cancer

Katsu Ishigaki, Hiroyuki Namba, Masahiro Nakashima et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 81 citations

Pathology, Reporter Gene, Tumor Biology +18